We understand that covered entities are extremely cautious about disclosing any 340B Program information related to their facility, patients, and contract pharmacies. The specificity of the information Kalderos is requesting within Kalderos Review has been authorized by our pharmaceutical manufacturer clients. Please find letters authorizing Kalderos to contact covered entities on behalf of our Kalderos Review clients below:
Alkermes
Amgen
AstraZeneca
Bausch Health
Biogen
Chiesi
Coherus BioSciences
Daiichi Sankyo (DSI)
Gilead
Merck
Napo
Sobi
Comments
0 comments
Please sign in to leave a comment.